Transcatheter valve-in-valve overexpansion for treating a large dysfunctional tricuspid bioprosthesis.
Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.
Department of Pediatric Cardiology, Centre Hospitalier Universitaire de Québec, Quebec City, QC, Canada.
- Published Article
Interactive Cardiovascular and Thoracic Surgery
Oxford University Press
- Publication Date
Mar 01, 2018
Transcatheter valve-in-valve implantation within dysfunctional surgical bioprosthesis has become an alternative to redo open-heart surgery. However, suitability for valve-in-valve implantation in the tricuspid position is often limited by large surgical valve sizes. We report a case of a transcatheter tricuspid valve-in-valve implantation with a 29-mm balloon-expandable prosthesis within a 33-mm failed bioprosthesis (exceeding manufacturer's sizing recommendations). Overexpansion of a 29-mm SAPIEN XT valve by 1-ml overfilling of the deployment balloon was successfully performed, with no valve dislocation/embolization or residual tricuspid regurgitation. This case illustrates the feasibility of tricuspid valve-in-valve procedures in selected patients with large failed tricuspid bioprostheses.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 10/20/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29087453